NCT05842824View on ClinicalTrials.gov

An Observational Study of Patients With Autoimmune Disease

Not yet recruitingOBSERVATIONAL
Enrollment

500,000

Participants

Timeline

Start Date

March 31, 2025

Primary Completion Date

December 31, 2038

Study Completion Date

December 31, 2038

Conditions
Autoimmune Diseases
All Listed Sponsors
lead

Target PharmaSolutions, Inc.

INDUSTRY